CoChat

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Open access
Babić, Mirjana, Švob Štrac, Dubravka, Mück-Šeler, Dorotea, Pivac, Nela, Stanić, Gabrijela, Hof, Patrick R., Šimić, Goran · 2014 · Croatian Medical Journal
Cited by 45

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited only patients with severe disease, who had not undergone disease-modifying therapies in preclinical stages of AD before severe degeneration occurred. Detection of AD in asymptomatic at risk individuals (and a few presymptomatic individuals who carry an autosomal dominant monogenic AD mutation) remains impractical in many of clinical situations and is possible only with reliable biomarkers. In addition to early diagnosis of AD, biomarkers should serve for monitoring disease progression and response to therapy. To date, the most promising biomarkers are cerebrospinal fluid (CSF) and neuroimaging biomarkers. Core CSF biomarkers (amyloid β1-42, total tau, and phosphorylated tau) showed a high diagnostic accuracy but were still unreliable for preclinical detection of AD. Hence, there is an urgent need for detection and validation of novel CSF biomarkers that would enable early diagnosis of AD in asymptomatic individuals. This article reviews recent research advances on biomarkers for AD, focusing mainly on the CSF biomarkers. In addition to core CSF biomarkers, the potential usefulness of novel CSF biomarkers is discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3325/cmj.2014.55.347

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 45

Metadata

Authors
Babić, M., Švob Štrac, D., Mück-Šeler, D., Pivac, N., Stanić, G., Hof, P. R., & Šimić, G.
Venue
Croatian Medical Journal
Published
2014-08
Volume
55
Issue
4
Pages
347-365
ISSN
  • 0353-9504 (ISSN-L)
  • 1332-8166
OpenAlex
W2131204905
Cited by
45
References
45
FWCI
2.92
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease. https://app.cochat.ai/papers/10.3325/cmj.2014.55.347
The paper
Babić, M., Švob Štrac, D., Mück-Šeler, D., Pivac, N., Stanić, G., Hof, P. R., & Šimić, G. (2014). Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease. Croatian Medical Journal. https://doi.org/10.3325/cmj.2014.55.347

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.